Gefurulimab
ALXN1720-MG-302
Phase 3 small_molecule active
Quick answer
Gefurulimab for Generalized Myasthenia Gravis with autoantibodies against acetylcholine receptor (AChR) is a Phase 3 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Generalized Myasthenia Gravis with autoantibodies against acetylcholine receptor (AChR)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active